LEC 29 Antivirals Flashcards
How does Acyclovir work?
What does it treat?
- Guanosine derivative that inhibits DNA synthesis
- Activated only in infected cells, bc it requires a viral kinase for the first of three phosporylation steps
Tx of HSV. Reduces symptoms and transmission d/t reduced viral shedding
What other HSV/CMV drugs have the same MOA as Acyclovir?
- Valacyclovir
- Penciclovir
- Famciclovir
What DNA synthesis drugs work better for CMV?
- Gancyclovir, Valganiclovir, Cidofovir - Slightly diff MOA; more active against CMV DNA Polymerase
- Foscarnet - different; works when resistance to gancyclovir is seen
How do nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) work?
- They inhibit reverse transcription
- NRTIs lack a 3’ OH group so the attachment of the next nucleotide is impossible
What do you know about Abacavir?
- NRTI
- Good oral F
- 12-24 h half life
- Resistance requires several mutations
What do you know about Didanosine?
- NRTI
- Good oral F
- Cellular metabolism and renal clearance
- Pancreatitis can be a problem - limit use in alcoholics
What do you know about Emtricitabine?
- NRTI
- Good oral F
- AE: hyperpigmentation of palms and soles
What do you know about Lamivudine?
- NRTI
- 80% F
- Well tolerated and possibly safer than didanosine
What do you know about Stavudine (d4T)?
- NRTI
- Good CNS penetration
What do you know about Tenofovir?
- NRTI
- Works well for HBV also
- Often co-administered with emtricitabine
What do we know about Zalcitabine?
- NRTI
- Can cause dose-dependent neuropathy (slowly reversible)
What do we know about Zidovudine (AZT)?
- NRTI
- First anti-retroviral
- Often co-administered with lamivudine
- Admin to preg women in late stage preg and neonates has been shown to reduce vertical transmission of HIV by 23%
What are the general adverse effects of NRTIs?
- Lactic acidosis
- Hepatomegaly, steatosis
- Not generally metabolized by CYP450 in liver
Which two NRTIs should NOT be co-administered?
Stavudine and Didanosine
How do NNRTIs work?
- Bind to a different site on the viral reverse transcriptase
- Result is the same – blocking RNA to DNA
- Highly susceptible to resistance through mutations in the pol gene - combine with other therapies